Levin Capital Strategies’s Gilead Sciences GILD Stock Holding History

Levin Capital Strategies’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-2,800	Closed	-$203K	–	351
2021 Q4	$203K	Buy	+2,800	New	+$193K	0.02%	270
2021 Q1	–	Sell	-2,800	Closed	-$163K	–	368
2020 Q4	$163K	Buy	+2,800	New	+$169K	0.02%	262
2017 Q3	–	Sell	-2,857	Closed	-$202K	–	354
2017 Q2	$202K	Buy	+2,857	New	+$190K	﹤0.01%	282
2017 Q1	–	Sell	-3,148	Closed	-$225K	–	317
2016 Q4	$225K	Sell	3,148 -2,175,722	-100%	-$162M	﹤0.01%	264
2016 Q3	$172K	Buy	2,178,870 +1,537,549	+240%	+$125M	2.54%	10
2016 Q2	$53.5M	Buy	641,321 +626,503	+4,228%	+$55.6M	0.96%	31
2016 Q1	$1.36M	Buy	+14,818	New	+$1.34M	0.02%	160
2015 Q1	–	Sell	-712,835	Closed	-$67.2M	–	404
2014 Q4	$67.2M	Buy	+712,835	New	+$73.7M	1.02%	26

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Levin Capital Strategies's GILD Position: Q1 2022 in Review

Levin Capital Strategies sold out of Gilead Sciences (GILD) in Q1 2022, closing a stake of 2,800 shares — an estimated $203K sold.

Levin Capital Strategies first reported a position in GILD in Q4 2014 and held it in 8 quarters. The position peaked at $67.2M in Q4 2014. 1,600 funds tracked by Wall St. Rank hold GILD as of Q1 2022.

Levin Capital Strategies reported no remaining Gilead Sciences position as of Q1 2022 after selling out during the quarter.
Levin Capital Strategies sold 2,800 Gilead Sciences shares in Q1 2022, an estimated $203K.
Levin Capital Strategies first reported a position in Gilead Sciences in Q4 2014 and held it in 8 quarters.
Levin Capital Strategies's Gilead Sciences position peaked at $67.2M in Q4 2014.
1,600 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2022.

Based on Levin Capital Strategies's 13F filing for Q1 2022, filed 2 May 2022.